Everpure, Inc.
NYSE:PIndustrial - Machinery
+$1.70 today
- Market cap
- $33.66B
- Beta
- 1.45
- P/E (TTM)
- 107.3
- EPS (TTM)
- $0.69
Volume 6.60M
Average 3.20M
P Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Everpure, Inc.NYSE: P
Research & Development · Q2 FY2027 · quarter ended Aug 2026
Research & development growth accelerates
Q2 FY2027 research & development of $293.75M rose 21.4% year over year, ahead of the +13.3% change in trailing-twelve-month research & development. Sequentially, it rose 13.4% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.
Context
- Research & development amounted to 26.3% of revenue in FY2026, up 0.9 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.4% holds above the trailing-twelve-month pace of +13.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 963.29M USD
- Year-over-year change
- +19.8%
- 4-year CAGR
- +13.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-02-01 | 963.29M | +19.8% |
| FY2025 | 2025-02-02 | 804.41M | +9.2% |
| FY2024 | 2024-02-04 | 736.76M | +6.4% |
| FY2023 | 2023-02-05 | 692.53M | +19.0% |
| FY2022 | 2022-02-06 | 581.94M | — |
Research & Development vs competitors
How P compares with its peers on the latest reported figures
- P's LTM Aug 2026 research & development of $996.09M is the 7th highest of the 11 companies compared; the peer median is $1.09B.
- Its year-over-year change of +13.3% is the 6th highest of 11, against a peer median of +14.6%.
- Research & development amounts to 23.4% of revenue for P, versus a peer median of 7.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $3.71B | +71.2% | +7.2% | 8.8% | |
| LTM Jul 2026 | $3.64B | +17.0% | +4.2% | 2.4% | |
| LTM Jul 2026 | $1.61B | +0.9% | -1.0% | 2.7% | |
| LTM Jul 2026 | $1.33B | +17.3% | +4.4% | 6.6% | |
| LTM Oct 2026 | $1.15B | +12.1% | +5.6% | 7.9% | |
| LTM Jul 2026 | $1.02B | +2.1% | +1.2% | 13.8% | |
| LTM Aug 2026 | $996.09M | +13.3% | +11.6% | 23.4% | |
| LTM Jun 2026 | $771.23M | +21.2% | +35.9% | 2.0% | |
| LTM Jul 2026 | $755M | +4.3% | -1.8% | 6.2% | |
| LTM Jun 2026 | $434.25M | +82.1% | +60.4% | 36.1% | |
| LTM Mar 2026 | $14.33M | +5.2% | +8.2% | 25.2% | |
| Peer median (excluding P) | $1.09B | +14.6% | +5.0% | 7.2% | |
Competitors are the stored peer set for P. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Feb 2022 | FY2023 Feb 2023 | FY2024 Feb 2024 | FY2025 Feb 2025 | FY2026 Feb 2026 |
|---|---|---|---|---|---|
| Revenue | 2.18B | 2.75B | 2.83B | 3.17B | 3.66B |
| Cost of Revenue | 708.33M | 855.79M | 809.43M | 955.46M | 1.08B |
| Gross Profit | 1.47B | 1.9B | 2.02B | 2.21B | 2.58B |
| Gross Margin | 67.5% | 68.9% | 71.4% | 69.8% | 70.4% |
| Research & Development | 581.94M | 692.53M | 736.76M | 804.41M | 963.29M |
| Selling, General & Admin | 988.98M | 1.12B | 1.2B | 1.31B | 1.38B |
| Operating Expenses | 1.57B | 1.81B | 1.97B | 2.13B | 2.46B |
| Depreciation & Amortization | 83.15M | 100.43M | 124.42M | 126.65M | 147.82M |
| EBITDA | (8.67M) | 196.99M | 222.49M | 282.3M | 379.44M |
| EBITDA Margin | -0.4% | 7.2% | 7.9% | 8.9% | 10.4% |
| Operating Income | (98.4M) | 83.51M | 53.55M | 85.26M | 114.82M |
| Operating Margin | -4.5% | 3.0% | 1.9% | 2.7% | 3.1% |
| Interest Income | 9.37M | 17.32M | 50.41M | 76.02M | 62.49M |
| Interest Expense | 36.68M | 4.75M | 7.48M | 7.81M | 3.38M |
| Other Income / Expenses | (30.1M) | 8.3M | 37.04M | 62.58M | 109.47M |
| Income Before Tax | (128.5M) | 91.81M | 90.59M | 147.83M | 224.28M |
| Pre-Tax Margin | -5.9% | 3.3% | 3.2% | 4.7% | 6.1% |
| Income Tax Expense | 14.76M | 18.74M | 29.28M | 41.1M | 36.1M |
| Net Income | (143.26M) | 73.07M | 61.31M | 106.74M | 188.18M |
| Net Margin | -6.6% | 2.7% | 2.2% | 3.4% | 5.1% |
| EPS (Basic) | (0.50) | 0.24 | 0.20 | 0.33 | 0.57 |
| EPS (Diluted) | (0.50) | 0.23 | 0.19 | 0.31 | 0.55 |
| Weighted Avg Shares | 285.88M | 299.48M | 311.83M | 325.77M | 328.54M |
| Weighted Avg Shares (Diluted) | 285.88M | 339.18M | 332.57M | 342.7M | 342.99M |
Everpure, Inc.
NYSE:P
Intrinsic Alpha fair value
Locked
Current Price
$101.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.